Diligence memo · auto-generated · as of July 2, 2026
Milagen, Inc.
Milagen, Inc. has raised $6.6M over 3 rounds; too few niche peers to rank its valuation yet.
Businessfiled
Milagen, Inc. operates in Biotechnology, based in EMERYVILLE.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Milagen, Inc. has raised $6.6M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $3.3M on 2002-03-15.
Most recent recorded round closed around 2002-03-15.
Valuation (modeled)modeled
Provath models Milagen, Inc. at approximately $147M (range $2.4M–$1.1B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Too few comparable companies in this niche to rank the valuation fairly yet.
Financing rhythm & timingmixed
Historic cadence: a new round about every 8 months.
Last raise 24.3 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 1.9× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 48% of Biotechnology peers (4293 compared).
Modeled value ranks above 66% of those peers.
Peoplefiled
1 named person on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.